Holthausen F F, von Müller F, Happel C, Kranert W T, Grünwald F
Dipl.-Ing. Christian Happel, Department of Nuclear Medicine, University Medical Center, Theodor Stern Kai 7, 60590 Frankfurt/Germany, Tel. +49/(0)69/63 01 43 30, E-mail:
Nuklearmedizin. 2015;54(1):20-5. doi: 10.3413/Nukmed-0673-14-06. Epub 2015 Jan 8.
Previous studies listed body surface area (BSA), lean body mass (LBM), and age as modifying factors on the TSH concentrations after administration of recombinant human thyrotropin (rhTSH). The purpose of this study was to identify the main modifying factors on serum TSH levels and to compare the stimulation via single rhTSH injection after a short thyroid hormone withdrawal (THW) with that of the standard stimulating protocol.
PATIENTS, METHODS: 106 patients with differentiated thyroid cancer (DTC) undergoing radioiodine therapy (RIT) after rhTSH administration were obtained through chart review. Two groups were evaluated: Group I was treated with a single rhTSH administration after two weeks of T3 therapy followed by one week of THW. Group II was stimulated according to the international standard protocol via rhTSH injections for two consecutive days. Serum TSH concentrations were documented prior to rhTSH administration (day 1 TSH), one day after (day 3 TSH) and 3-6 days after (mean 4.2 days, day 6 TSH) the last rhTSH injection. The following data was collected: age, gender, weight, height, BMI, LBM, BSA, residual thyroid tissue, CRP, creatinine, GFR, liver enzymes, alkaline phosphatase, cholesterol, and triglycerides.
Group I: Age combined with anthropometric factors like BMI (TSH increase and day 6 TSH), BSA (TSH decrease), and gender (day 6 TSH) are the main modifying factors on serum TSH concentrations after rhTSH administration. Group II: Age and lean body mass (LBM) showed a significant impact on day 3 TSH, TSH increase (day 3-day 1), and TSH decrease (day 6-day 3). Day 6 TSH was found to be influenced by GFR (group II).
Age and anthropometric parameters have significant independent influence on TSH concentrations after rhTSH injection in both groups. Anthropometric parameters (BSA, LBM) and demographic parameters (female gender) show strong influence on TSH concentrations. Further research should be conducted to examine the influence of body compartments on TSH levels through measuring total body water.
以往研究将体表面积(BSA)、瘦体重(LBM)和年龄列为重组人促甲状腺素(rhTSH)给药后促甲状腺激素(TSH)浓度的修正因素。本研究的目的是确定血清TSH水平的主要修正因素,并比较短期甲状腺激素撤药(THW)后单次注射rhTSH与标准刺激方案的刺激效果。
患者、方法:通过病历审查获得106例接受rhTSH给药后行放射性碘治疗(RIT)的分化型甲状腺癌(DTC)患者。评估两组:第一组在T3治疗两周后单次给予rhTSH,随后进行一周的THW。第二组按照国际标准方案连续两天注射rhTSH进行刺激。在rhTSH给药前(第1天TSH)、最后一次rhTSH注射后一天(第3天TSH)和3 - 6天(平均4.2天,第6天TSH)记录血清TSH浓度。收集以下数据:年龄、性别、体重、身高、体重指数(BMI)、LBM、BSA、残余甲状腺组织、C反应蛋白(CRP)、肌酐、肾小球滤过率(GFR)、肝酶、碱性磷酸酶、胆固醇和甘油三酯。
第一组:年龄与BMI(TSH升高和第6天TSH)、BSA(TSH降低)和性别(第6天TSH)等人体测量因素是rhTSH给药后血清TSH浓度的主要修正因素。第二组:年龄和瘦体重(LBM)对第3天TSH、TSH升高(第3天 - 第1天)和TSH降低(第6天 - 第3天)有显著影响。发现第6天TSH受GFR影响(第二组)。
年龄和人体测量参数对两组rhTSH注射后的TSH浓度有显著的独立影响。人体测量参数(BSA、LBM)和人口统计学参数(女性性别)对TSH浓度有强烈影响。应通过测量总体水来进一步研究身体各部分对TSH水平的影响。